Evidence map›Paper›PMID 42773285›Full record

ArticleNature cardiovascular research2026

Bioadaptive spatiotemporal nanomedicine promotes metabolic recovery after myocardial infarction through NAD

Jue Wang, Yingci Xia, Wenxuan Zheng, Wenqin Yuan, Yunying Huang, Yuntao Zhang, Qiong Huang, Kelong Ai

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cardiovascular research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jue WangDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
Yingci XiaDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
Wenxuan ZhengDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
Wenqin YuanDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
Yunying HuangDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
Yuntao ZhangDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
Qiong HuangDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, China. qionghuang@csu.edu.cn.ORCID http://orcid.org/0000-0002-0570-5961
Kelong AiXiangya School of Pharmaceutical Sciences, Central South University, Changsha, China. aikelong@csu.edu.cn.ORCID http://orcid.org/0000-0002-9863-8963

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82574405
6 · The paper itself

Abstract

Myocardial infarction causes persistent mitochondrial and metabolic dysfunction that drives adverse cardiac remodeling. Here we develop NAD

Identifiers

PMID42773285

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.